Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Apr-24 8:11 PM View:  | Mazabraud Yann EVP, Head of International | Rhythm Pharmaceuticals, Inc. (RYTM) | 14-Apr-24 | Option Exercise | 10,375 | -- | -- | (23%) 45.24K to 34.87K | |
| 03-Apr-24 8:00 PM View: | German Christopher Paul Corporate Controller & CAO | Rhythm Pharmaceuticals, Inc. (RYTM) | 02-Apr-24 | Planned Option Sale | 368 | $41.76 | $15,367.70 | (32%) 1.16K to 0.8K | |
| 22-Mar-24 4:55 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 21-Mar-24 | Private Sale (Planned) | 18,235 | $40.34 | $735,600.00 | (100%) 18.27K to 30 | |
| 22-Mar-24 4:16 PM View: | Chien Jennifer EVP, Head of North America | Rhythm Pharmaceuticals, Inc. (RYTM) | 20-Mar-24 | Private Sale (Planned) | 18,235 | $38.77 | $707,005.00 | (73%) 25.09K to 6.85K | |
| 03-Apr-24 8:00 PM View: | German Christopher Paul Corporate Controller & CAO | Rhythm Pharmaceuticals, Inc. (RYTM) | 20-Mar-24 | Option Exercise | 1,163 | -- | -- | 100% 0 to 1.16K | |
| 19-Mar-24 8:56 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 15,515 | $39.22 | $608,498.00 | (46%) 33.78K to 18.27K | |
| 19-Mar-24 8:57 PM View: | Smith Hunter C Chief Financial Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 15,515 | $39.22 | $608,498.00 | (14%) 113.45K to 97.94K | |
| 19-Mar-24 8:54 PM View: | Meeker David P President and CEO Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 45,494 | $39.22 | $1,784,270.00 | (21%) 220.1K to 174.6K | |
| 19-Mar-24 8:50 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 15,515 | $39.22 | $608,498.00 | (34%) 45.52K to 30.0K | |
| 19-Mar-24 8:53 PM View: | Mazabraud Yann EVP, Head of International | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 16,000 | $39.22 | $627,520.00 | (40%) 40.49K to 24.5K | |
| 19-Mar-24 8:52 PM View: | Chien Jennifer EVP, Head of North America | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 15,515 | $39.22 | $608,498.00 | (38%) 40.6K to 25.09K | |
| 21-Feb-24 7:01 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 16-Feb-24 | Grant | 33,750 | -- | -- | 287% 11.77K to 45.52K | |
| 21-Feb-24 7:02 PM View: | Mazabraud Yann EVP, Head of International | Rhythm Pharmaceuticals, Inc. (RYTM) | 16-Feb-24 | Grant | 33,750 | -- | -- | 500% 6.75K to 40.49K | |
| 21-Feb-24 7:01 PM View: | Smith Hunter C Chief Financial Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 16-Feb-24 | Grant | 33,750 | -- | -- | 42% 79.7K to 113.45K | |
| 21-Feb-24 7:00 PM View: | Chien Jennifer EVP, Head of North America | Rhythm Pharmaceuticals, Inc. (RYTM) | 16-Feb-24 | Grant | 33,750 | -- | -- | 493% 6.85K to 40.6K | |
| 21-Feb-24 7:00 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 16-Feb-24 | Grant | 33,750 | -- | -- | 112500% 30 to 33.78K | |
| 21-Feb-24 7:03 PM View: | Meeker David P President and CEO Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 16-Feb-24 | Grant | 99,000 | -- | -- | 82% 121.1K to 220.1K | |
| 15-Feb-24 6:14 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 14-Feb-24 | Sale (Planned) | 1,089 | $50.01 | $54,460.90 | (97%) 1.12K to 30 | |
| 13-Feb-24 8:46 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 13-Feb-24 | Planned Option Sale | 473 | $49.84 | $23,574.30 | (14%) 3.46K to 2.98K | |
| 15-Feb-24 6:14 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 13-Feb-24 | Private Sale (Planned) | 1,865 | $50.00 | $93,250.00 | (62%) 2.98K to 1.12K | |
| 13-Feb-24 8:50 PM View: | Smith Hunter C Chief Financial Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 13-Feb-24 | Planned Option Sale | 709 | $49.82 | $35,322.40 | (< 1%) 80.41K to 79.7K | |
| 13-Feb-24 8:49 PM View: | Mazabraud Yann EVP, Head of International | Rhythm Pharmaceuticals, Inc. (RYTM) | 13-Feb-24 | Planned Option Sale | 957 | $49.84 | $47,696.90 | (12%) 7.7K to 6.75K | |
| 13-Feb-24 8:47 PM View: | Chien Jennifer EVP, Head of North America | Rhythm Pharmaceuticals, Inc. (RYTM) | 13-Feb-24 | Planned Option Sale | 615 | $49.83 | $30,645.50 | (8%) 7.47K to 6.85K | |
| 13-Feb-24 8:50 PM View: | Smith Hunter C Chief Financial Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 12-Feb-24 | Planned Option Sale | 1,209 | $51.38 | $62,118.40 | (1%) 81.62K to 80.41K | |
| 13-Feb-24 8:49 PM View: | Mazabraud Yann EVP, Head of International | Rhythm Pharmaceuticals, Inc. (RYTM) | 12-Feb-24 | Planned Option Sale | 1,594 | $51.38 | $81,899.70 | (17%) 9.3K to 7.7K | |
| 13-Feb-24 8:47 PM View: | Chien Jennifer EVP, Head of North America | Rhythm Pharmaceuticals, Inc. (RYTM) | 12-Feb-24 | Planned Option Sale | 1,023 | $51.38 | $52,561.70 | (12%) 8.49K to 7.47K | |
| 13-Feb-24 8:45 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 12-Feb-24 | Planned Option Sale | 696 | $51.38 | $35,760.50 | (6%) 12.47K to 11.77K | |
| 13-Feb-24 8:46 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 12-Feb-24 | Planned Option Sale | 791 | $51.38 | $40,641.60 | (19%) 4.25K to 3.46K | |
| 13-Feb-24 8:50 PM View: | Smith Hunter C Chief Financial Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 11-Feb-24 | Option Exercise | 2,344 | -- | -- | 3% 79.28K to 81.62K | |
| 13-Feb-24 8:47 PM View: | Chien Jennifer EVP, Head of North America | Rhythm Pharmaceuticals, Inc. (RYTM) | 11-Feb-24 | Option Exercise | 2,031 | -- | -- | 31% 6.46K to 8.49K | |
| 13-Feb-24 8:46 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 11-Feb-24 | Option Exercise | 1,562 | -- | -- | 58% 2.69K to 4.25K | |
| 13-Feb-24 8:49 PM View: | Mazabraud Yann EVP, Head of International | Rhythm Pharmaceuticals, Inc. (RYTM) | 11-Feb-24 | Option Exercise | 2,031 | -- | -- | 28% 7.26K to 9.3K | |
| 13-Feb-24 8:50 PM View: | Smith Hunter C Chief Financial Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Feb-24 | Option Exercise | 4,063 | -- | -- | 5% 75.22K to 79.28K | |
| 13-Feb-24 8:47 PM View: | Chien Jennifer EVP, Head of North America | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Feb-24 | Option Exercise | 3,438 | -- | -- | 114% 3.02K to 6.46K | |
| 13-Feb-24 8:46 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Feb-24 | Option Exercise | 71,846 | $20.59 | $1,479,280.00 | 2749% 2.61K to 74.46K | |
| 13-Feb-24 8:46 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Feb-24 | Planned Option Sale | 71,774 | $50.38 | $3,615,980.00 | (96%) 74.46K to 2.69K | |
| 13-Feb-24 8:49 PM View: | Mazabraud Yann EVP, Head of International | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Feb-24 | Option Exercise | 3,438 | -- | -- | 90% 3.83K to 7.26K | |
| 13-Feb-24 8:45 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Feb-24 | Option Exercise | 2,344 | -- | -- | 23% 10.12K to 12.47K | |
| 05-Feb-24 6:54 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 01-Feb-24 | Option Exercise | 3,938 | -- | -- | 100% 0 to 3.94K | |
| 05-Feb-24 6:54 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 01-Feb-24 | Planned Option Sale | 1,324 | $45.06 | $59,659.40 | (34%) 3.94K to 2.61K | |
| 05-Feb-24 6:53 PM View: | Meeker David P President and CEO Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 01-Feb-24 | Option Exercise | 14,125 | -- | -- | 13% 111.33K to 125.46K | |
| 05-Feb-24 6:53 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 01-Feb-24 | Planned Option Sale | 946 | $45.06 | $42,626.80 | (9%) 11.07K to 10.12K | |
| 05-Feb-24 6:53 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 01-Feb-24 | Option Exercise | 2,650 | -- | -- | 31% 8.42K to 11.07K | |
| 05-Feb-24 6:53 PM View: | Meeker David P President and CEO Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 01-Feb-24 | Planned Option Sale | 4,361 | $45.06 | $196,507.00 | (3%) 125.46K to 121.1K | |
| 05-Feb-24 6:54 PM View: | Smith Hunter C Chief Financial Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 01-Feb-24 | Option Exercise | 4,925 | -- | -- | 7% 71.91K to 76.83K | |
| 05-Feb-24 6:54 PM View: | Smith Hunter C Chief Financial Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 01-Feb-24 | Planned Option Sale | 1,616 | $45.06 | $72,817.00 | (2%) 76.83K to 75.22K | |
| 05-Feb-24 6:55 PM View: | Chien Jennifer EVP, Head of North America | Rhythm Pharmaceuticals, Inc. (RYTM) | 01-Feb-24 | Option Exercise | 4,513 | -- | -- | 100% 0 to 4.51K | |
| 05-Feb-24 6:55 PM View: | Chien Jennifer EVP, Head of North America | Rhythm Pharmaceuticals, Inc. (RYTM) | 01-Feb-24 | Planned Option Sale | 1,492 | $45.06 | $67,229.50 | (33%) 4.51K to 3.02K | |
| 03-Jan-24 4:15 PM View: | Smith Hunter C Chief Financial Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 29-Dec-23 | Option Exercise | 10,500 | $6.88 | $72,240.00 | 17% 61.41K to 71.91K | |
| 29-Dec-23 4:30 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 28-Dec-23 | Sale (Planned) | 3,741 | $50.00 | $187,059.00 | (100%) 3.74K to 0 |
